The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
M | Musculo-skeletal system | |
2
|
M01 | Antiinflammatory and antirheumatic products | |
3
|
M01A | Antiinflammatory and antirheumatic products, non-steroids | |
4
|
M01AB | Acetic acid derivatives and related substances | |
5
|
M01AB05 | Diclofenac |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 0.1 g | |
| PAREN | Parenteral | 0.1 g | |
| RECTAL | Rectal | 0.1 g |
| Active Ingredient |
|---|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| Document | Type | Information Source | |
|---|---|---|---|
| AKIS Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ALMIRAL Gastro-resistant tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| ALMIRAL Gel | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| ALMIRAL Solution for injection / infusion | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| ALMIRAL Suppositories | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| ARESTON Film-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| CAMBIA Powder for oral solution | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| CATAFAST Powder for oral solution | MPI, EU: SmPC | Medicines Authority (MT) | |
| CATAFLAM Sugar coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| DICLAC Enteric-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| DICLAC Solution for injection | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| DICLOFLEX Prolonged-release tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| DIFENE Modified‑release capsule | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| MOTIFENE Capsule, hard | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MOTIFINE Capsule, hard | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| REMETHAN Gastro-resistant tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| REMETHAN Gel | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| REMETHAN Prolonged-release tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| REMETHAN Suppository | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| TAKS Gastro-resistant tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| TAKS Solution for injection or infusion | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| VELTEX Capsule / Solution for injection | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| VOLTAROL Medicated Plaster | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VOLTAROL OPTHA MULTIDOSE Eye drops solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VOLTAROL PAIN-EZE EMULGEL Gel for topical administration | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VOLTAROL RAPID Coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VOLTAROL Suppositories | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VOLTFAST Powder for oral solution | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| ZORVOLEX Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.